Both plasma and urine redox biomarkers can be used to assess systemic antioxidant status in patients with adrenal tumors. Sun et al. developed a computed tomography (CT) -based radiological-clinical ...

The FDA has accepted Merck's (MRK) supplemental NDA with priority review for its drug Welireg for the treatment of a rare ...

Adrenal disorders are complex and require a healthcare provider that has expertise ... Your physician may also request additional imaging and laboratory testing to confirm a diagnosis and develop your ...

Doctors at Queen Mary University of London, Barts Health NHS Trust, and University College London have led the development of a simple, minimally invasive Targeted Thermal Therapy (Triple T) that has ...

Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its Welireg oral cancer drug in patients with rare tumors that form in and around the ...

The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic pheochromocytoma and paraganglioma.

Industry giants like Takeda Pharmaceuticals, Pfizer, Novartis, and Bayer are revolutionizing treatment landscapes, paving the way for enhanced patien ...

Cushing syndrome presents with a wide array of symptoms, many of which result from prolonged exposure to elevated cortisol ...

The FDA accepts and grants priority review to Merck's sNDA for Welireg to treat advanced pheochromocytoma and paraganglioma.

An oft-repeated message is that primary aldosteronism is not rare; it is quite common. An equally urgent message is that ...

Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of ...